On Monday, Gritstone Bio Inc (NASDAQ: GRTS) opened lower -31.78% from the last session, before settling in for the closing price of $0.05. Price fluctuations for GRTS have ranged from $0.05 to $3.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 230.33%. Company’s average yearly earnings per share was noted 30.00% at the time writing. With a float of $110.21 million, this company’s outstanding shares have now reached $118.11 million.
Let’s determine the extent of company efficiency that accounts for 231 employees. In terms of profitability, gross margin is -325.12%, operating margin of -8786.76%, and the pretax margin is -7825.47%.
Gritstone Bio Inc (GRTS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Gritstone Bio Inc is 6.69%, while institutional ownership is 30.02%. The most recent insider transaction that took place on May 16 ’24, was worth 18,156. In this transaction PRESIDENT AND CEO of this company sold 24,263 shares at a rate of $0.75, taking the stock ownership to the 985,360 shares. Before that another transaction happened on May 16 ’24, when Company’s EVP, CHIEF OPERATING OFFICER sold 13,749 for $0.75, making the entire transaction worth $10,288. This insider now owns 359,293 shares in total.
Gritstone Bio Inc (GRTS) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.33 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.33) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.00% per share during the next fiscal year.
Gritstone Bio Inc (NASDAQ: GRTS) Trading Performance Indicators
Check out the current performance indicators for Gritstone Bio Inc (GRTS). In the past quarter, the stock posted a quick ratio of 2.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.77 in one year’s time.
Technical Analysis of Gritstone Bio Inc (GRTS)
Looking closely at Gritstone Bio Inc (NASDAQ: GRTS), its last 5-days average volume was 115.19 million, which is a jump from its year-to-date volume of 7.01 million. As of the previous 9 days, the stock’s Stochastic %D was 0.97%. Additionally, its Average True Range was 0.04.
During the past 100 days, Gritstone Bio Inc’s (GRTS) raw stochastic average was set at 0.15%, which indicates a significant decrease from 0.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 493.30% in the past 14 days, which was higher than the 260.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4019, while its 200-day Moving Average is $1.1683. However, in the short run, Gritstone Bio Inc’s stock first resistance to watch stands at $0.0380. Second resistance stands at $0.0438. The third major resistance level sits at $0.0473. If the price goes on to break the first support level at $0.0287, it is likely to go to the next support level at $0.0252. Now, if the price goes above the second support level, the third support stands at $0.0194.
Gritstone Bio Inc (NASDAQ: GRTS) Key Stats
There are currently 108,569K shares outstanding in the company with a market cap of 3.80 million. Presently, the company’s annual sales total 16,340 K according to its annual income of -138,490 K. Last quarter, the company’s sales amounted to 920 K and its income totaled -23,400 K.
